Opting Out of Cervical Cancer Screening

Physicians Who Do Not Perform Pap Tests


      Some primary care physicians choose not to provide cervical cancer screening.


      To investigate the characteristics and screening beliefs of family practitioners and internists who treat adult women in outpatient settings but perform no routine Pap tests.


      A survey of U.S. primary care physicians (N=892) was conducted and analyzed in 2012.


      Participants who performed no Pap tests during a typical month (17.2% of family practitioners and 44.3% of internists) generally reported that they referred patients to gynecologists for cervical cancer screening. The most significant predictor of Pap test non-provision was agreement that patients are best served by having Pap tests performed by gynecologists (AOR=8.80, 95% CI=5.58, 13.88, p<0.001).


      The perception that patients benefit from cervical cancer screening administered by gynecologists may deter screening in primary care settings, resulting in missed opportunities to offer screening to women who are never or rarely screened.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • U.S. Preventive Services Task Force
        Screening for Cervical Cancer: Clinical Summary of U.S. Preventive Services Task Force Recommendation.
        AHRQ Publication No. 11-05156-EF-3. 2012;
        • Subramaniam A.
        • Fauci J.M.
        • Schneider K.E.
        • et al.
        Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?.
        J Low Genit Tract Dis. 2011; 15: 110-113
        • Sung H.Y.
        • Kearney K.A.
        • Miller M.
        • Kinney W.
        • Sawaya G.F.
        • Hiatt R.A.
        Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
        Cancer. 2000; 88: 2283-2289
        • Leyden W.A.
        • Manos M.M.
        • Geiger A.M.
        • et al.
        Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
        J Natl Cancer Inst. 2005; 97: 675-683
        • Kinney W.
        • Sung H.Y.
        • Kearney K.A.
        • Miller M.
        • Sawaya G.
        • Hiatt R.A.
        Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC).
        Gynecol Oncol. 1998; 71: 428-430
        • Janerich D.T.
        • Hadjimichael O.
        • Schwartz P.E.
        • et al.
        The screening histories of women with invasive cervical cancer, Connecticut.
        Am J Public Health. 1995; 85: 791-794
        • Merritt Hawkins & Associates
        2009 survey of physician appointment wait times.
        Meritt Hawkins & Associates, Irving TX2009
        • Rayburn W.F.
        • Klagholz J.C.
        • Murray-Krezan C.
        • Dowell L.E.
        • Strunk A.L.
        Distribution of American Congress of Obstetricians and Gynecologists fellows and junior fellows in practice in the U.S.
        Obstet Gynecol. 2012; 119: 1017-1022
        • Cohen D.
        • Coco A.
        Do physicians address other medical problems during preventive gynecologic visits?.
        J Am Board Fam Med. 2014; 27: 13-18
        • Yabroff K.R.
        • Saraiya M.
        • Meissner H.I.
        • et al.
        Specialty differences in primary care physician reports of Papanicolaou test screening practices: a national survey, 2006 to 2007.
        Ann Intern Med. 2009; 151: 602-611
        • Cumming R.G.
        Is probability sampling always better? A comparison of results from a quota and a probability sample survey.
        Community Health Stud. 1990; 14: 132-137
        • Stewart R.A.
        • Thistlethwaite J.
        • Evans R.
        Pelvic examination of asymptomatic women: attitudes and clinical practice.
        Aust Fam Physician. 2008; 37: 493-496
        • Sawaya G.F.
        New guidelines—it’s complicated.
        Obstet Gynecol. 2013; 121: 703-704
        • Lurie N.
        • Slater J.
        • McGovern P.
        • Ekstrum J.
        • Quam L.
        • Margolis K.
        Preventive care for women. Does the sex of the physician matter?.
        N Engl J Med. 1993; 329: 478-482
        • Ince-Cushman D.
        • Correa J.A.
        • Shuldiner J.
        • Segouin J.
        Association of primary care physician sex with cervical cancer and mammography screening.
        Can Fam Physician. 2013; 59: e11-e18
        • Almeida C.M.
        • Rodriguez M.A.
        • Skootsky S.
        • Pregler J.
        • Steers N.
        • Wenger N.S.
        Cervical cancer screening overuse and underuse: patient and physician factors.
        Am J Manag Care. 2013; 19: 482-489
        • Berkowitz Z.
        • Saraiya M.
        • Benard V.
        • Yabroff K.R.
        Common abnormal results of pap and human papillomavirus cotesting: what physicians are recommending for management.
        Obstet Gynecol. 2010; 116: 1332-1340
      1. U.S. Department of Health and Human Services, Read the Law.

        • Levy A.R.
        • Bruen B.K.
        • Ku L.
        Health care reform and women’s insurance coverage for breast and cervical cancer screening.
        Prev Chronic Dis. 2012; 9: E159
        • Gee R.E.
        Preventive services for women under the Affordable Care Act.
        Obstet Gynecol. 2012; 120: 12-14